Exploring the Influence of Genetic Vulnerability to Neurodevelopmental Disorders on Antipsychotic Efficacy in Schizophrenia: Insights from a Postmortem Brain Analysis - Top-Institutions - MDSpire

Exploring the Influence of Genetic Vulnerability to Neurodevelopmental Disorders on Antipsychotic Efficacy in Schizophrenia: Insights from a Postmortem Brain Analysis

  • By

  • Kazusa Miyahara

  • Mizuki Hino

  • Risa Shishido

  • Atsuko Nagaoka

  • Hideomi Hamasaki

  • Akiyoshi Kakita

  • Hiroaki Tomita

  • Yasuto Kunii

  • April 27, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Psychiatric Genetics
    • Neurodevelopmental Disorders
    • Genomics

  • #2

    Stanley Center for Psychiatric Research, Broad Institute
    Stanley Center for Psychiatric Research, Broad Institute

    Cambridge, MA

    Key Differentiators

    • Psychiatric Genomics
    • Neurobiology of Mental Illness

  • #3

    National Institute of Mental Health (NIMH)
    National Institute of Mental Health (NIMH)

    Bethesda, MD

    Key Differentiators

    • Psychiatry
    • Neurogenetics
    • Clinical Neuroscience

  • #4

    University of California, San Francisco (UCSF) Weill Institute for Neurosciences
    University of California, San Francisco (UCSF) Weill Institute for Neurosciences

    San Francisco, CA

    Key Differentiators

    • Neuropsychiatry
    • Genetics
    • Neurodevelopmental Disorders

  • #5

    King's College London, Institute of Psychiatry, Psychology & Neuroscience (IoPPN)
    King's College London, Institute of Psychiatry, Psychology & Neuroscience (IoPPN)

    London, N/A

    Key Differentiators

    • Psychiatric Genetics
    • Neurodevelopmental Disorders
    • Clinical Neuroscience

Original Source(s)

Exploring the Influence of Genetic Vulnerability to Neurodevelopmental Disorders on Antipsychotic Efficacy in Schizophrenia: Insights from a Postmortem Brain Analysis

  • by Kazusa Miyahara, Mizuki Hino, Risa Shishido, Atsuko Nagaoka, Hideomi Hamasaki, Akiyoshi Kakita, Hiroaki Tomita, Yasuto Kunii

  • April 27, 2026

Related Content

Innovation to Improve Detection of Early Developmental and Behavioral Concerns

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease

Plasma microRNA signatures in drug-Naïve Romanian adolescents with First-Episode Psychosis